ARC in Hemorrhagic Stroke

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Augmented Renal Clearance
Hemorrhagic Stroke

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02386202
14-1491

Details and patient eligibility

About

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults ≥ 18 years
  • Patients with hemorrhagic stroke
  • Anticipated length of stay in the neuroscience intensive care unit > 48 hours
  • Informed consent provided by the patient or by the patient's designated medical proxy

Exclusion criteria

  • Pregnancy
  • Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5)
  • Patients receiving renal replacement therapy
  • Patients with an admission serum creatinine > 1.4 mg/dL
  • Patients with non-aneurysmal subarachnoid hemorrhage
  • Patients with history of nephrectomy or body mass index < 18 kg/m2

Trial design

80 participants in 1 patient group

Patients with hemorrhagic stroke
Description:
All patients with hemorrhagic stroke admitted to the neurosciences ICU are eligible for study enrollment.
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems